Skip to main content

COVID-19 Topic Center

Mental Health News

News
There is very little evidence supporting the treatment of mental health disorders with cannabis, according to the results of a recent meta-analysis. Although it has been suggested that cannabinoids and their synthetic derivatives could be used for the treatment of mental health disorders, their…
News
While effects on depressive symptoms took longer, sertraline eased anxiety symptoms and improved self-reported mental health within 6 weeks in primary care patients with symptoms of depression, according to a study published online in The Lancet Psychiatry. “We have found important evidence that…
News
Antidepressant use appears to be safe, according to a systematic umbrella review of 45 meta-analyses spanning more than 1000 observational studies. Researchers published findings from their review online in JAMA Psychiatry. “As far as we know, this is the first study to assess the safety and…
News
By Anne Harding NEW YORK (Reuters Health) - Antidepressants are associated with a 35% reduced risk of mortality in patients with diabetes mellitus (DM) and depression, a retrospective study suggests. "This data provides further rationale for the screening and treating of depression in persons…
News
On Tuesday, the U.S. Food and Drug Administration (FDA) approved a drug to treat patients suffering from peroxisomal disorders and acid synthesis disorders caused by single enzyme defects. Cholic acid (Cholbam) is approved to treat both children, ages three weeks and older, and adults who have…
Back to Top